BNC protects H9c2 cardiomyoblasts from H2O2-induced oxidative injury through ERK1/2 signaling pathway

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Zhang, Fangbo ^a   Huang, Bin ^a   Zhao, Ye ^a   Tang, Shihuan ^a   Xu, Haiyu ^a   Wang, Lan ^a   Liang, Rixin ^a   Yang, Hongjun ^a  

^a INSTITUTE OF CHINESE MATERIA MEDICA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; BUCHANG NAOXINTONG CAPSULE; CASPASE 3; CATALASE; CHINESE DRUG; HYDROGEN PEROXIDE; MALONALDEHYDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TRIMETAZIDINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CELL DAMAGE; CELL DEATH; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENCY; ENZYME INHIBITION; HEART PROTECTION; IN VITRO STUDY; INTESTINE ABSORPTION; MALE; MITOCHONDRIAL MEMBRANE POTENTIAL; MYOFIBROBLAST; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION;

EID: 84886682616     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/802784     Document Type: Article

References (31)

1. Dhalla N. S., Temsah R. M., Netticadan T., Role of oxidative stress in cardiovascular diseases. Journal of Hypertension 2000 18 6 655 673 2-s2.0-0034083227 (Pubitemid 30406736)
2. Higashi Y., Noma K., Yoshizumi M., Kihara Y., Endothelial function and oxidative stress in cardiovascular diseases. Circulation Journal 2009 73 3 411 418 2-s2.0-62649123264 10.1253/circj.CJ-08-1102
3. Crow M. T., Mani K., Nam Y. J., Kitsis R. N., The mitochondrial death pathway and cardiac myocyte apoptosis. Circulation Research 2004 95 10 957 970 2-s2.0-8844235617 10.1161/01.RES.0000148632.35500.d9 (Pubitemid 39532326)
4. Simon H. U., Haj-Yehia A., Levi-Schaffer F., Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis 2000 5 5 415 418 2-s2.0-0034468736 10.1023/A:1009616228304 (Pubitemid 32162623)
5. Halliwell B., Reactive oxygen species in living systems: source, biochemistry, and role in human disease. The American Journal of Medicine C 1991 91 supplement 3 S14 S22 2-s2.0-4244087065
6. Dhalla N. S., Elmoselhi A. B., Hata T., Makino N., Status of myocardial antioxidants in ischemia-reperfusion injury. Cardiovascular Research 2000 47 3 446 456 2-s2.0-0034683031 10.1016/S0008-6363(00)00078-X (Pubitemid 30646067)
7. Aikawa R., Komuro I., Yamazaki T., Zou Y., Kudoh S., Tanaka M., Shiojima I., Hiroi Y., Yazaki Y., Oxidative stress activates extracellular signal-regulated kinases through Src and Ras in cultured cardiac myocytes of neonatal rats. Journal of Clinical Investigation 1997 100 7 1813 1821 2-s2.0-0030886770 (Pubitemid 27431340)
8. Adderley S. R., Fitzgerald D. J., Oxidative damage of cardiomyocytes is limited by extracellular regulated kinases 1/2-mediate induction of cyclooxygenase-2. The Journal of Biological Chemistry 1999 274 8 5038 5046 2-s2.0-0033582464 10.1074/jbc.274.8.5038 (Pubitemid 29113410)
9. Napoli C., de Nigris F., Palinski W., Multiple role of reactive oxygen species in the arterial wall. Journal of Cellular Biochemistry 2001 82 4 674 682 2-s2.0-0034894990 10.1002/jcb.1198 (Pubitemid 32720682)
10. Zhang H., Wang W. R., Lin R., Zhang J.-Y., Ji Q.-L., Lin Q.-Q., Yang L.-N., Buyang Huanwu decoction ameliorates coronary heart disease with Qi deficiency and blood stasis syndrome by reducing CRP and CD40 in rats. Journal of Ethnopharmacology 2010 130 1 98 102 2-s2.0-77953808121 10.1016/j.jep.2010.04. 017
11. Zhao J., Zhu H., Wang S., Naoxintong protects against Atherosclerosis through lipid-lowering and inhibiting maturation of dendritic cells in LDL receptor knockout mice fed a high-fat diet. Current Pharmaceutical Design 2013 19 33 5891 5896
12. Chen H., Zhang Y., Wu X., Li C., Wang H., In vitro assessment of cytochrome P450 2C19 potential of Naoxintong. Evidence-Based Complementary and Alternative Medicine 2012 2012 6 2-s2.0-84858163376 10.1155/2012/430262 430262
13. Chen H., Yu G., Sun H., Wu X., Wang H., Comparison of adjunctive naoxintong versus clopidogrel in volunteers with the CYP2C19 2 gene mutation accompanied with qi deficiency and blood stasis constitution. Evidence-Based Complementary and Alternative Medicine 2011 2011 10 2-s2.0-79955165371 10.1155/2011/207034 207034
14. 2-induced oxidative stress in endothelial cells. Free Radical Biology and Medicine 2006 40 12 2206 2213 2-s2.0-33745124769 10.1016/j.freeradbiomed.2006.02.017 (Pubitemid 43903105)
15. Danchin N., Clinical benefits of a metabolic approach with trimetazidine in revascularized patients with angina. The American Journal of Cardiology 2006 98 5 8J 13J 2-s2.0-33747365277 10.1016/j.amjcard.2006.07.003
16. Wisel S., Khan M., Kuppusamy M. L., Mohan I. K., Chacko S. M., Rivera B. K., Sun B. C., Hideg K., Kuppusamy P., Pharmacological preconditioning of mesenchymal stem cells with trimetazidine (1-[2,3,4-trimethoxybenzyl]piperazine) protects hypoxic cells against oxidative stress and enhances recovery of myocardial function in infarcted heart through Bcl-2 expression. Journal of Pharmacology and Experimental Therapeutics 2009 329 2 543 550 2-s2.0-65649150660 10.1124/jpet.109.150839
17. Kevin L. G., Novalija E., Stowe D. F., Reactive oxygen species is mediators of cardiac injury and protection: the relevance to anesthesia practice. Anesthesia and Analgesia 2005 101 5 1275 1287 2-s2.0-27444444994 10.1213/01.ANE.0000180999.81013.D0 (Pubitemid 41531857)
18. Suleiman M. S., Halestrap A. P., Griffiths E. J., Mitochondria: a target for myocardial protection. Pharmacology and Therapeutics 2001 89 1 29 46 2-s2.0-0035059412 10.1016/S0163-7258(00)00102-9 (Pubitemid 32367882)
19. Dedkova E. N., Blatter L. A., Measuring mitochondrial function in intact cardiac myocytes. Journal of Molecular and Cellular Cardiology 2012 52 1 48 61 2-s2.0-84155189038 10.1016/j.yjmcc.2011.08.030
20. Franklin J. L., Redox regulation of the intrinsic pathway in neuronal apoptosis. Antioxidants and Redox Signaling 2011 14 8 1437 1448 2-s2.0-79952825980 10.1089/ars.2010.3596
21. Dorn G. W. II, Apoptotic and non-apoptotic programmed cardiomyocyte death in ventricular remodelling. Cardiovascular Research 2009 81 3 465 473 2-s2.0-59449098471 10.1093/cvr/cvn243
22. Murphy E., Steenbergen C., Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiological Reviews 2008 88 2 581 609 2-s2.0-42049108814 10.1152/physrev.00024.2007 (Pubitemid 351520088)
23. Garrington T. P., Johnson G. L., Organization and regulation of mitogen-activated protein kinase signaling pathways. Current Opinion in Cell Biology 1999 11 2 211 218 2-s2.0-0032910168 10.1016/S0955-0674(99)80028-3 (Pubitemid 29164036)
24. Sugden P. H., Clerk A., Oxidative stress and growth-regulating intracellular signaling pathways in cardiac myocytes. Antioxidants and Redox Signaling 2006 8 11-12 2111 2124 2-s2.0-33947689707 (Pubitemid 46489635)
25. Capodici C., Pillinger M. H., Han G., Philips M. R., Weissmann G., Integrin-dependent homotypic adhesion of neutrophils. Arachidonic acid activates Raf-1/Mek/Erk via a 5-lipoxygenase-dependent pathway. Journal of Clinical Investigation 1998 102 1 165 175 2-s2.0-0032128337 (Pubitemid 28323843)
26. Wang Z. Q., Wu D. C., Huang F. P., Yang G. Y., Inhibition of MEK/ERK 1/2 pathway reduces pro-inflammatory cytokine interleukin-1 expression in focal cerebral ischemia. Brain Research 2004 996 1 55 66 2-s2.0-0344665661 10.1016/j.brainres.2003.09.074 (Pubitemid 37510294)
27. Roux P. P., Blenis J., ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiology and Molecular Biology Reviews 2004 68 2 320 344 2-s2.0-2942530310 10.1128/MMBR.68.2.320-344.2004 (Pubitemid 38756868)
28. Chen Y., Wang J., Yuan L., Zhou L., Jia X., Tan X., Interaction of the main components from the traditional Chinese drug pair Chaihu-Shaoyao based on rat intestinal absorption. Molecules 2011 16 11 9600 9610 2-s2.0-82255184186 10.3390/molecules16119600
29. Liu J. Y., Lee K. F., Sze C. W., Intestinal absorption and bioavailability of traditional Chinese medicines: a review of recent experimental progress and implication for quality control. Journal of Pharmacy and Pharmacology 2013 65 5 621 633
30. Kutala V. K., Khan M., Mandal R., Ganesan L. P., Tridandapani S., Kalai T., Hideg K., Kuppusamy P., Attenuation of myocardial ischemia-reperfusion injury by trimetazidine derivatives functionalized with antioxidant properties. Journal of Pharmacology and Experimental Therapeutics 2006 317 3 921 928 2-s2.0-33646814422 10.1124/jpet.105.100834 (Pubitemid 43764093)
31. Dedkova E. N., Seidlmayer L. K., Blatter L. A., Mitochondria-mediated cardioprotection by trimetazidine in rabbit heart failure. Journal of Molecular and Cellular Cardiology 2013 59 41 54